Combinations of a specific HCV NS5A inhibitor and an HCV NS3 protease inhibitor

Details for Australian Patent Application No. 2010307144 (hide)

Owner Bristol-Myers Squibb Company

Inventors Lemm, Julie A.; Voss, Stacey A.; Gao, Min; Chaniewski, Susan E.; Sheaffer, Amy K.; McPhee, Fiona

Agent A J Park

Pub. Number AU-A-2010307144

PCT Pub. Number WO2011/046811

Priority 61/250,648 12.10.09 US; 12/899,840 07.10.10 US

Filing date 8 October 2010

Wipo publication date 21 April 2011

International Classifications

A61K 38/06 (2006.01) Medicinal preparations containing peptides - Tripeptides

A61K 31/4178 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

3 May 2012 PCT application entered the National Phase

  PCT publication WO2011/046811 Priority application(s): WO2011/046811

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010307151-Ammonia pretreatment of biomass for improved inhibitor profile

2010307140-Multi-modality contrast and brightfield context rendering for enhanced pathology determination and multi-analyte detection in tissue